CEDRUS’s HCA Healthcare HCA Stock Holding History

CEDRUS’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$448K	Sell	1,103 -217	-16%	-$79.4K	0.17%	101
2024 Q2	$424K	Sell	1,320 -72	-5%	-$23.4K	0.21%	88
2024 Q1	$464K	Sell	1,392 -33	-2%	-$10.1K	0.25%	74
2023 Q4	$386K	Buy	1,425 +1	+0.1%	+$247	0.24%	89
2023 Q3	$350K	Sell	1,424 -17	-1%	-$4.65K	0.25%	87
2023 Q2	$437K	Sell	1,441 -74	-5%	-$20.6K	0.31%	61
2023 Q1	$399K	Buy	1,515 +24	+2%	+$6.1K	0.28%	76
2022 Q4	$358K	Buy	1,491 +4	+0.3%	+$896	0.29%	82
2022 Q3	$273K	Sell	1,487 -2	-0.1%	-$398	0.26%	83
2022 Q2	$250K	Buy	1,489 +86	+6%	+$18.5K	0.24%	91
2022 Q1	$352K	Buy	1,403 +196	+16%	+$49.2K	0.32%	77
2021 Q4	$310K	Buy	+1,207	New	+$295K	0.3%	96

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CEDRUS's HCA Position: Q3 2024 in Review

CEDRUS reduced its HCA Healthcare (HCA) stake by 16% in Q3 2024, selling an estimated $79.4K and leaving 1,103 shares worth $448K. The position accounts for 0.17% of the portfolio, ranked #101.

CEDRUS first reported a position in HCA in Q4 2021 and has held it in 12 quarters since. The position peaked at $464K in Q1 2024. 1,203 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

CEDRUS held 1,103 shares of HCA Healthcare worth $448K as of Q3 2024.
CEDRUS sold 217 HCA Healthcare shares in Q3 2024, an estimated $79.4K.
HCA Healthcare made up 0.17% of CEDRUS's portfolio in Q3 2024, its #101 holding.
CEDRUS first reported a position in HCA Healthcare in Q4 2021 and has held it in 12 quarters since.
CEDRUS's HCA Healthcare position peaked at $464K in Q1 2024.
1,203 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.